Optimizing Gene-Based Testing for Antibiotic Resistance Prediction
This work addresses the critical global health challenge of antibiotic resistance by developing more efficient diagnostic tools for clinical settings, though it appears incremental as it builds on existing methods with specific enhancements.
The study tackled the problem of predicting antibiotic resistance by optimizing gene selection for PCR tests, introducing GenoARM, a framework that integrates reinforcement learning with transformer models to improve accuracy, particularly when using metadata and more genes, achieving superior performance compared to baselines.
Antibiotic Resistance (AR) is a critical global health challenge that necessitates the development of cost-effective, efficient, and accurate diagnostic tools. Given the genetic basis of AR, techniques such as Polymerase Chain Reaction (PCR) that target specific resistance genes offer a promising approach for predictive diagnostics using a limited set of key genes. This study introduces GenoARM, a novel framework that integrates reinforcement learning (RL) with transformer-based models to optimize the selection of PCR gene tests and improve AR predictions, leveraging observed metadata for improved accuracy. In our evaluation, we developed several high-performing baselines and compared them using publicly available datasets derived from real-world bacterial samples representing multiple clinically relevant pathogens. The results show that all evaluated methods achieve strong and reliable performance when metadata is not utilized. When metadata is introduced and the number of selected genes increases, GenoARM demonstrates superior performance due to its capacity to approximate rewards for unseen and sparse combinations. Overall, our framework represents a major advancement in optimizing diagnostic tools for AR in clinical settings.